Elan buys share of Theravance royalties on new drug for $1B; Vivus bulks up its board in anticipation of proxy fight;

Two businessmen shaking hands in a hallway

@FiercePharma: FDA nixes Endo petition to protect Opana ER from generics. Article | Follow @FiercePharma

> Irish drugmaker Elan ($ELN) snapped up a 21% share of Theravance ($THRX) royalties on a newly approved respiratory drug to be sold by GlaxoSmithKline ($GSK) in a $1 billion deal aimed at strengthening its defense against a buyout bid by Royalty Pharma. Report

> Vivus ($VVUS), under pressure from investors unhappy with its obesity drug marketing, has added two more directors to its board at a time when shareholder First Manhattan has proposed its own slate of 6 nominees. Report

> Two North Dakota men joined the hundreds who have sued Takeda Pharmaceutical, claiming the company's diabetes drug Actos caused their bladder cancer. Report

> GlaxoSmithKline and Save the Children teamed up in a 5-year, $23 million deal to improve healthcare and vaccination in the developing world. Report

Medical Device News

@FierceMedDev: Boston Scientific's Watchman AF device generates more stunning data. Story | Follow @FierceMedDev

@MarkHFierce: Swiss stent maker Bioensors Int'l will pay $51M for a U.S. imaging company - diversification program now under way. More | Follow @MarkHFierce

 @DamianFierce: Glaxo is reaching into Hong Kong with a new DKSH partnership, targeting antibiotics. Article | Follow @DamianFierce

> Israel's budding medical device industry begins to flower. Item

> Sorin wins FDA nod for cardiac monitor. News

> Michigan State develops blood Dx for childhood malaria complication. DxExtra

Biotech News

@FierceBiotech:  FDA accepts $BIIB's BLA for 1st long-lasting factor VIII therapy for hemophilia A. Release | Follow @FierceBiotech

@JohnCFierce: J&J gets a priority review for hep C drug simeprevir (with Medivir). More | Follow @JohnCFierce

@RyanMFierce:  Mobile service PharmaSecure finds demand in losing fight against fake drugs. Story | Follow @RyanMFierce

> Vectura joins forces with a new JV biotech in China for respiratory therapies. News

> Class action suits pile up at Aveo's doorstep in wake of FDA debacle. More

> Elan pays $1B for a slice of Theravance's COPD franchise royalty stream. News

CRO News

> Argentine CRO Stat Research taps Datatrak. News

> Harlan Labs doubles in specialty research with U.S. expansion. Story

> PRA boosts informatics with Welsh expansion. More

> Quintiles hauls in $947M IPO after upping offering. Report

> AMRI piles on profits with strong Q2. Article

Biotech IT News

> Pfizer tests online Viagra sales to beat the cheats. News

> IT outfit Instem acquires Logos to penetrate early clinical trials market. More

> GlaxoSmithKline exec details expectations for online clinical trial research. Article

> Hong Kong billionaire backs Big Data effort in biomedicine at Oxford University. Story

> Pfizer opts to keep running Accelrys software in its labs. Article

And Finally... Scientists found a biomarker in patients' noses that may be linked to schizophrenia. Report